Nipro newsletter April 2026
tjoapck banner – feb 2026
Carterra 23/09/25
LB Bohle – 10.06.2025
PCI – 7th June 2024
Temax_Krautz
Media Pack
News

Current Edition

Volume 18, Issue 1
Merxin March 2026
Chemspec Feb 2026
the bridge – website ad 28/01/2026
Terumo 05/01
SAE Media – pre-filled syringes – East Coast 19/11/25
SAE Media – Pre-filled syringes West Coast 19/11/25
Nipro April 2026
Volume 15 Issue 2

Advancements of Gene Editing Technologies(CRISPR/Cas9)

An Introduction to Gene Editing – CRISPR-Cas9 The dynamic promise of gene editing for humans is the ability to precisely manipulate the sequence of the cell genom...
3 July 2023 Volume 15 Issue 2 Advancements | cell
Continue Reading →
Volume 15 Issue 2

Gene Edited iPSCs May Find a Place in Allogeneic Therapies

An Introduction to Pluripotency Pluripotent: adjective; capable of giving rise to many different cell types. This is the hallmark characteristic of the induced pl...
3 July 2023 Volume 15 Issue 2 allogeneic | cell
Continue Reading →
News

Bioprocessing Technologies in Stem Cell Research

    The 2nd Stem Cell Community Day brings together experts from industry and academia to discuss recent achievements, challenges, and chances in stem cel...
27 March 2018 News bioprocessing | cell
Continue Reading →
News

SYGNIS AG signs supply agreement with US Biological for the Lightning-Link antibody labelling technology

SYGNIS AG, the Group which includes Expedeon Holdings, Innova Biosciences, and C.B.S. Scientific Company, today announced it has signed a supply agreement with ...
28 November 2017 News antibody | biological
Continue Reading →
News

Symcel secures €3.6 million Horizon 2020 Phase II grant for clinical validation of customized antimicrobial susceptibility testing

Symcel, the company behind the revolutionary cell-based assay tool for real-time cell metabolism measurements, calScreener™, has secured €3.572 million Horizon 2020 ...
21 November 2017 News antibiotic | assay
Continue Reading →
News

Elpis BioMed closes funding round to commercialise novel technology platform for generating human cell types

Elpis BioMed Ltd (Elpis), a University of Cambridge spin-out, applying its disruptive and proprietary “direct cell reprogramming” platform to produce pure, mature an...
20 November 2017 News application | cell
Continue Reading →
News

Genmab Achieves USD 50 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen

Genmab has announced that it has achieved a USD 50 million sales volume milestone in its DARZALEX® (daratumumab) collaboration with Janssen Biotech, Inc.  The m...
17 November 2017 News antibody | cancer
Continue Reading →
News

IDBS takes Bioprocess Execution Solution to the Cloud

IDBS announces the release of its latest Bioprocess Execution (BPES) informatics solution. Leveraging the IDBS E-WorkBook Cloud platform, the solution provides an ou...
9 November 2017 News bioprocess | cell
Continue Reading →
SMI London
Biopharma group march 2026
Interpack Staubli March 2026
Silgan March 2026
Scott Pharma – 25.03.2025
Bespak – 21.05.2025
Aptar – 08/01/2026
Stoelzle – 15th May 2025
L.B. Bohle – 08.04.2025
logo-ipi-w.png

International Pharmaceutical Industry

IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative

Facebook Linkedin Tumblr
IPI Media © 2026, All Rights Reserved – Powered by Teksyte